Accelerate Your Success: Harnessing Virtual Twins in Biopharma

Unlock the potential of virtual twins to optimize production, ensure compliance, and accelerate your biopharma growth journey

The Future of Biopharma: Leveraging Virtual Twins for Growth

The biopharmaceutical market generates $163 billion globally, representing 20% of the pharma industry and growing over 8% annually—twice the rate of conventional pharma, according to McKinsey. This growth is expected to continue.

Are your biopharma operations ready to adapt to changing regulations, market demands, or supply chain disruptions?

In our e-book, you will learn how to:

  • Streamline development and regulatory compliance to accelerate product launches
  • Adopt best practices for scaling production without sacrificing quality or incurring high costs
  • Leverage predictive analytics and scenario testing to proactively improve yield, reduce waste, and minimize downtime
Transforming Biopharma Manufacturing Efficiency Text Brick > Brick Visual > Dassault Systèmes®

Check out our datasheet here

DELMIA’s Line Simulation and Optimization solution, powered by the 3DEXPERIENCE platform, enables biopharmaceutical manufacturers to create and optimize a virtual twin of their entire plant, production line or specific processes.

Download eBook now

Download